Woburn, Mass.-based GeneXP this week named a seven-person scientific advisory board including: David Evans, head of drug discovery for the Translational Genomics Research Institute; Geoff Ginsburg, vice president, molecular medicine and research strategy, Millennium; Glenn Hoke, president and chief science officer, Dyad Pharmaceuticals and former vice president of research and development, Gene Logic; Josh LaBaer, director, Harvard Institute of Proteomics, Harvard Medical School; John Quackenbush, investigat